Elite Pharmaceuticals, Inc. (ELTP)
0.2422
-0.01
(-2.14%)
USD |
OTCM |
Sep 21, 16:00
Elite Pharmaceuticals EPS Diluted (TTM) : 0.0263 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0263 |
| March 31, 2026 | 0.0156 |
| December 31, 2025 | 0.0217 |
| September 30, 2025 | 0.0056 |
| June 30, 2025 | -0.0101 |
| March 31, 2025 | -0.004 |
| December 31, 2024 | -0.0167 |
| September 30, 2024 | -0.0058 |
| June 30, 2024 | 0.0191 |
| March 31, 2024 | 0.0196 |
| December 31, 2023 | 0.0148 |
| September 30, 2023 | 0.017 |
| June 30, 2023 | 0.0039 |
| March 31, 2023 | 0.0031 |
| December 31, 2022 | 0.0071 |
| September 30, 2022 | 0.006 |
| June 30, 2022 | 0.0059 |
| March 31, 2022 | 0.008 |
| December 31, 2021 | 0.0051 |
| September 30, 2021 | 0.0053 |
| June 30, 2021 | 0.0053 |
| March 31, 2021 | 0.004 |
| December 31, 2020 | 0.0056 |
| September 30, 2020 | 0.0014 |
| June 30, 2020 | -0.0019 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0045 |
| December 31, 2019 | -0.0088 |
| September 30, 2019 | -0.0099 |
| June 30, 2019 | -0.0112 |
| March 31, 2019 | -0.0118 |
| December 31, 2018 | -0.0121 |
| September 30, 2018 | -0.0102 |
| June 30, 2018 | -0.0098 |
| March 31, 2018 | -0.0103 |
| December 31, 2017 | -0.0103 |
| September 30, 2017 | -0.0088 |
| June 30, 2017 | -0.0075 |
| March 31, 2017 | -0.0063 |
| December 31, 2016 | 0.029 |
| September 30, 2016 | -0.0211 |
| June 30, 2016 | -0.0257 |
| March 31, 2016 | -0.0106 |
| December 31, 2015 | -0.0524 |
| September 30, 2015 | -0.0058 |
| June 30, 2015 | -0.0097 |
| March 31, 2015 | -0.0334 |
| December 31, 2014 | -0.2109 |
| September 30, 2014 | -0.2096 |
| June 30, 2014 | -0.2196 |
| March 31, 2014 | -0.208 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Nektar Therapeutics | -6.697 |
| Daré Bioscience, Inc. | -0.7856 |
| Eton Pharmaceuticals, Inc. | 0.3783 |
| ANI Pharmaceuticals, Inc. | 4.632 |
| Corcept Therapeutics, Inc. | 0.4187 |